SEOUL (Reuters) – South Korean has begun a review of Johnson & Johnson’s coronavirus vaccine after the U.S. pharmaceutical firm submitted an application for approval, the government said on Saturday.
The food and drug safety ministry said it would study the one-shot vaccine with private advisory panels before it authorises the vaccine.
(Reporting by Cynthia Kim, Sangmi Cha; Editing by Clarence Fernandez)
